RN7SL316P

Across TCGA pan-cancer cohorts, RN7SL316P RNA differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of RN7SL316P’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal papillary cell carcinoma (KIRP), where RN7SL316P RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RN7SL316P is over-expressed in tumor.

KIRP, LUSC, and LUAD are the cancer types where RN7SL316P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RN7SL316P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRP	All	All	+0.317	<.001	5	view →
LUSC	Male	All	+0.183	.001	4	view →
LUAD	All	II,III,IV	+0.138	.007	4	view →
CHOL	All	II,III,IV	+0.335	<.001	2	view →
KIRC	Male	II,III,IV	+0.053	.022	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

RN7SL316P–KIRP

Open the KIRP breakdown →